Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Nutex Health (NUTX) Net Income towards Common Stockholders: 2009-2024

Historic Net Income towards Common Stockholders for Nutex Health (NUTX) over the last 14 years, with FY2024 value amounting to $52.2 million.

  • Nutex Health's Net Income towards Common Stockholders rose 145099.79% to $96.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $227.9 million, marking a year-over-year increase of 80702.04%. This contributed to the annual value of $52.2 million for FY2024, which is 21396.16% up from last year.
  • Per Nutex Health's latest filing, its Net Income towards Common Stockholders stood at $52.2 million for FY2024, which was up 21396.16% from -$45.8 million recorded in FY2023.
  • Over the past 5 years, Nutex Health's Net Income towards Common Stockholders peaked at $119.8 million during FY2021, and registered a low of -$424.8 million during FY2022.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was $52.2 million (2024), whereas its average is -$39.9 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first crashed by 45468.19% in 2022, then soared by 21396.16% in 2024.
  • Nutex Health's Net Income towards Common Stockholders (Annual) stood at $98.9 million in 2020, then grew by 21.1% to $119.8 million in 2021, then crashed by 454.68% to -$424.8 million in 2022, then skyrocketed by 89.22% to -$45.8 million in 2023, then surged by 213.96% to $52.2 million in 2024.
  • Its last three reported values are $52.2 million in FY2024, -$45.8 million for FY2023, and -$424.8 million during FY2022.